chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Acute myocardial infarction, Echocardiogram, Electrocardiogram normal, Pericardial disease, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Pericarditis
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425030. A 21-year-old male patient received the following vaccination on 23 May 2011: a left arm ACAM2000 (sanofi pasteur lot number VV04003A). The patient had no current illnesses and no medical history. On 02 June 2011, the patient required an Emergency visit and was hospitalized due to pericarditis which was manifested by chest pain. The outcome was reported as recovered. Documents held by sender: None.
Age: 27.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Fatigue, Pain in extremity, Rash
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425064. A 27-year-old male patient received the following vaccination on 11 May 2011: a left arm ACAM2000 (sanofi pasteur lot number VV04003A). The patient's had no medical history, no current illnesses, and took no current medications. On 20 May 2011, the patient started feeling tired. On 21 May 2011, the patient's arm was "really sore" and a "streak" of red moving towards the armpit was noticed. On 22 May 2011, the streak moved down to the bicep. The patient went to the Emergency Room (ER) on 22 May 2011 and was given two intravenous (IV) antibiotics. The patient was diagnosed by the ER doctor with vaccine induced rash. The patient required hospitalization. The outcome was reported as recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Rash erythematous, Scab, Skin lesion
Clinical narrative: Initial report received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425331. A 20-year-old male patient with no medical history, no use of other medications, and no concurrent illnesses, had received the following vaccinations on 07 June 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV281) and 2 days later developed a lesion on the chin and multiple lesions to the suprapubic area. At onset he had red bumps that progressed to crusted lesions. At present the patient is a self inoculator versus opportunistic infections. He was to be evaluated by his primary care manager. Recovery status was not reported. Note: The manufacturer also captured autoinoculation as an event. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Post vaccination autoinoculation, Rash erythematous, Scab, Skin lesion
Clinical narrative: Initial report received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425331. A 20-year-old male patient with no medical history, no use of other medications, and no concurrent illnesses, had received the following vaccinations on 07 June 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV281) and 2 days later developed a lesion on the chin and multiple lesions to the suprapubic area. At onset he had red bumps that progressed to crusted lesions. At present the patient is a self inoculator versus opportunistic infections. He was to be evaluated by his primary care manager. Recovery status was not reported. Note: The manufacturer also captured autoinoculation as an event. Documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site reaction, Scab, Skin lesion
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425369. A 27-year-old female patient received the following vaccination on 12 May 2011: a left deltoid ACAM2000 (sanofi pasteur lot  number VV04003A (reported as lot number VV00403A)). The patient had no current illnesses, no medical history and took no other medications. On 20 May 2011, the patient developed autoinoculation 2 cm below site of vaccine (on left deltoid) as well as below chin. Currently each site (as well as vaccine site) has lesion with 40-50% scabbing. The patient noticed the lesion 5 days ago. The outcome was not reported. Note: The manufacturer also captured autoinoculation as an event. Documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site reaction, Post vaccination autoinoculation, Scab, Skin lesion
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425369. A 27-year-old female patient received the following vaccination on 12 May 2011: a left deltoid ACAM2000 (sanofi pasteur lot  number VV04003A (reported as lot number VV00403A)). The patient had no current illnesses, no medical history and took no other medications. On 20 May 2011, the patient developed autoinoculation 2 cm below site of vaccine (on left deltoid) as well as below chin. Currently each site (as well as vaccine site) has lesion with 40-50% scabbing. The patient noticed the lesion 5 days ago. The outcome was not reported. Note: The manufacturer also captured autoinoculation as an event. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest X-ray normal, Chest discomfort, Chest pain, Electrocardiogram normal
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425433. A 21-year-old male patient received the following vaccination on 10 May 2011: a left arm ACAM2000 (SP Biologics Co. lot number not reported). The patient had a current illness of nasal congestion with postnasal drip for 2-4 days prior to the vaccine. The patient had a history of attention deficit disorder (ADD). His concomitant medications included ADDERALL and CLARITIN as needed (PRN). On 11 May 2011, 24-48 hours after receiving the ACAM2000, the patient developed for less than 1 hour chest ache/pressure at rest described as "2 hands grabbing at lower chest" 24 hours after vaccination. Later he had a 2-3 hour ache to 2-4th intercostal space (ICS) right sided of sternum 48 hours after ACAM2000 vaccine which resolved with activity. The patient went to the Emergency Room (ER) on 12 May 2011. The patient had a normal electrocardiogram (EKG) and chest x-ray (CXR). The patient was released with the diagnosis of chest pain-resolved. The patient was sent to the clinic for follow-up for his chest pressure. He had no recurrence of this discomfort. The patient did report a 2-4 day history of light AM cough prior to vaccination (?URI vs allergic rhinitis PND?). The outcome was reported as recovered. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest discomfort, Chest pain
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425433. A 21-year-old male patient received the following vaccination on 10 May 2011: a left arm ACAM2000 (SP Biologics Co. lot number not reported). The patient had a current illness of nasal congestion with postnasal drip for 2-4 days prior to the vaccine. The patient had a history of attention deficit disorder (ADD). His concomitant medications included ADDERALL and CLARITIN as needed (PRN). On 11 May 2011, 24-48 hours after receiving the ACAM2000, the patient developed for less than 1 hour chest ache/pressure at rest described as "2 hands grabbing at lower chest" 24 hours after vaccination. Later he had a 2-3 hour ache to 2-4th intercostal space (ICS) right sided of sternum 48 hours after ACAM2000 vaccine which resolved with activity. The patient went to the Emergency Room (ER) on 12 May 2011. The patient had a normal electrocardiogram (EKG) and chest x-ray (CXR). The patient was released with the diagnosis of chest pain-resolved. The patient was sent to the clinic for follow-up for his chest pressure. He had no recurrence of this discomfort. The patient did report a 2-4 day history of light AM cough prior to vaccination (?URI vs allergic rhinitis PND?). The outcome was reported as recovered. Documents held by sender: None.
Age: 29.0
Sex: M
Vaccine: ANTH, SMALL, TDAP, ANTH, SMALL, TDAP
Symptoms: Encephalitis post immunisation
Clinical narrative: This study case was received from the investigator in a trial on 06 June 2011. A 29 year-old male subject with no significant medical history was found to have encephalitis following immunization procedures 9 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported), Anthrax 2 (manufacturer, lot number, route and site of administration not reported) and Tdap (manufacturer, lot number, route and site of administration not reported) on 08 August 2010. He also received on 11 July 2010 an injection Anthrax 1 (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data was not available. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425441. No further information was provided at the time of the report. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericardial disease, Pericarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator in a trial on 06 June 2011. A 24 year-old male subject with no significant medical history was found to have other and unspecified acute pericarditis and an unspecified disease of the pericardium 15 and 14 days respectively after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 03 January 2011. Relevant laboratory data included: an abnormal Troponin I result with the highest recorded value of 20.07, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425442. No further information was provided at the time of the report. Documents held by sender: none.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Pericardial disease, Pericarditis, Troponin I
Clinical narrative: This study case was received from the investigator on 06 June 2011. A 21 year-old male subject whose medical history was not available for dizziness/fainting spells, blood clots, shortness of breath, asthma (include exercise induced), Diabetes (Type I or Type II), eczema, headaches, numbness or paralysis, seizures, memory loss, chronic fatigue syndrome, psychiatric illness, HIV, meningitis and encephalitis (all other medical history was not significant) was found to have acute pericarditis, unspecified and an unspecified disease of the pericardium 11 days after he had received an injection of ACAM2000 (lot number, route and site of administration not reported) on 12 November 2010. He also received on 15 October 2010 Hepatitis A (Adult) (manufacturer, lot number, route and site of administration not reported) and on 13 October 2010 he received Influenza vaccine (manufacturer, lot number, route and site of administration not reported), IPV (manufacturer, lot number, route and site of administration not reported), Meningococcal MCV4P (manufacturer, lot number, route and site of administration not reported) and Tdap (manufacturer, lot number, route and site of administration not reported). Relevant laboratory data included: a normal Troponin I result, an abnormal ECG and a normal Echocardiogram. Treatments were not reported. Additional information will be requested from the investigator. The subject's outcome was not reported. Note: There was no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425443. No further information was provided at the time of the report. Documents held by sender: none
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Echocardiogram, Electrocardiogram abnormal, Pericardial disease, Troponin I
Clinical narrative: This study case was received from the investigator in a trial on 10 June 2011. A 23-year-old male subject, with no significant medical history, received an injection of ACAM2000, sanofi pasteur Inc. lot not reported, an injection of TYPHIM VI, sanofi pasteur SA lot number not reported, and an injection of Anthrax, manufacturer and lot number not reported, on 01 February 2011. On 07 February 2011, the subject had an abnormal electrocardiogram (ECG). The results of the subject's Troponin I and echocardiogram were not available. On the 24 February 2011, the subject was diagnosed with unspecified disease of the pericardium. The outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425453. No further information was provided at the time of the report. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Epistaxis, Petechiae, Platelet count decreased
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Activated partial thromboplastin time, Antinuclear antibody, Blood folate, Blood immunoglobulin G, Blood immunoglobulin M
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Blood iron normal, Chest X-ray normal, Computerised tomogram abnormal, Cytomegalovirus test positive, Ecchymosis
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Epstein-Barr virus antigen positive, HIV test negative, HLA marker study, Haptoglobin normal, Idiopathic thrombocytopenic purpura
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Immunoglobulin therapy, Intensive care, International normalised ratio, Iron binding capacity total, Lymphocyte count
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Metabolic function test normal, Parasite blood test, Petechiae, Platelet count decreased, Platelet function test normal
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Prothrombin time normal, Serum ferritin, Serum ferritin normal, Splenomegaly, Toxoplasma serology negative
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: HEPAB, SMALL, YF, HEPAB, SMALL, YF, SMALL
Symptoms: Vitamin B12
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 425738. A 22-year-old male patient received the following vaccination (date not reported): ACAM2000 (lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient's medical history was denied. He took no other medications and his current illnesses were unknown. On 20 June 2011, the patient developed a petechiae rash and nosebleed for one day. The patient required an Emergency visit and was hospitalized for a life threatening event. The patient's platelet count was found to be decreased. The outcome was reported as unknown. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Blood test normal, C-reactive protein increased, Chest X-ray normal, Chest discomfort, Chest pain
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426081. A 22-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000 (sanofi pasteur lot number VV04003A) and BIOTHRAX (Michigan DPH, lot number FAV256). The patient had no medical history, no current illnesses and took no other medications. The patient received the smallpox vaccine and the anthrax vaccine (dose 1) on 31 May 2011 in preparation for a trip in late July. The patient was a combat medic. On about day 8 (onset date reported as 07 June 2011), he developed severe chest pressure/pain. A chest x-ray and electrocardiogram (EKG) were reportedly normal. He was treated with MOTRIN 800 milligrams (mg) three times a day (tid) without relief. He was seen by cardiology where blood work and an echocardiogram were also reportedly normal/negative. He was diagnosed with pericarditis unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs) and placed on (COLCHICINE) yesterday. Today the pain continues but maybe a little eased. He was scheduled for a magnetic resonance imaging (MRI) and follow-up with cardiology on the 23rd. Follow-up would be after the patient was seen. The outcome was reported as not recovered. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Dyspnoea, Echocardiogram normal, Electrocardiogram normal, Pain, Pericarditis
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426081. A 22-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000 (sanofi pasteur lot number VV04003A) and BIOTHRAX (Michigan DPH, lot number FAV256). The patient had no medical history, no current illnesses and took no other medications. The patient received the smallpox vaccine and the anthrax vaccine (dose 1) on 31 May 2011 in preparation for a trip in late July. The patient was a combat medic. On about day 8 (onset date reported as 07 June 2011), he developed severe chest pressure/pain. A chest x-ray and electrocardiogram (EKG) were reportedly normal. He was treated with MOTRIN 800 milligrams (mg) three times a day (tid) without relief. He was seen by cardiology where blood work and an echocardiogram were also reportedly normal/negative. He was diagnosed with pericarditis unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs) and placed on (COLCHICINE) yesterday. Today the pain continues but maybe a little eased. He was scheduled for a magnetic resonance imaging (MRI) and follow-up with cardiology on the 23rd. Follow-up would be after the patient was seen. The outcome was reported as not recovered. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426081. A 22-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000 (sanofi pasteur lot number VV04003A) and BIOTHRAX (Michigan DPH, lot number FAV256). The patient had no medical history, no current illnesses and took no other medications. The patient received the smallpox vaccine and the anthrax vaccine (dose 1) on 31 May 2011 in preparation for a trip in late July. The patient was a combat medic. On about day 8 (onset date reported as 07 June 2011), he developed severe chest pressure/pain. A chest x-ray and electrocardiogram (EKG) were reportedly normal. He was treated with MOTRIN 800 milligrams (mg) three times a day (tid) without relief. He was seen by cardiology where blood work and an echocardiogram were also reportedly normal/negative. He was diagnosed with pericarditis unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs) and placed on (COLCHICINE) yesterday. Today the pain continues but maybe a little eased. He was scheduled for a magnetic resonance imaging (MRI) and follow-up with cardiology on the 23rd. Follow-up would be after the patient was seen. The outcome was reported as not recovered. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Blood test normal, Chest X-ray normal, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426081. A 22-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000 (sanofi pasteur lot number VV04003A) and BIOTHRAX (Michigan DPH, lot number FAV256). The patient had no medical history, no current illnesses and took no other medications. The patient received the smallpox vaccine and the anthrax vaccine (dose 1) on 31 May 2011 in preparation for a trip in late July. The patient was a combat medic. On about day 8 (onset date reported as 07 June 2011), he developed severe chest pressure/pain. A chest x-ray and electrocardiogram (EKG) were reportedly normal. He was treated with MOTRIN 800 milligrams (mg) three times a day (tid) without relief. He was seen by cardiology where blood work and an echocardiogram were also reportedly normal/negative. He was diagnosed with pericarditis unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs) and placed on (COLCHICINE) yesterday. Today the pain continues but maybe a little eased. He was scheduled for a magnetic resonance imaging (MRI) and follow-up with cardiology on the 23rd. Follow-up would be after the patient was seen. The outcome was reported as not recovered. Documents held by sender: None.
Age: 22.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram normal, Pericarditis
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426081. A 22-year-old male patient received the following vaccinations on 31 May 2011: ACAM2000 (sanofi pasteur lot number VV04003A) and BIOTHRAX (Michigan DPH, lot number FAV256). The patient had no medical history, no current illnesses and took no other medications. The patient received the smallpox vaccine and the anthrax vaccine (dose 1) on 31 May 2011 in preparation for a trip in late July. The patient was a combat medic. On about day 8 (onset date reported as 07 June 2011), he developed severe chest pressure/pain. A chest x-ray and electrocardiogram (EKG) were reportedly normal. He was treated with MOTRIN 800 milligrams (mg) three times a day (tid) without relief. He was seen by cardiology where blood work and an echocardiogram were also reportedly normal/negative. He was diagnosed with pericarditis unresponsive to nonsteroidal anti-inflammatory drugs (NSAIDs) and placed on (COLCHICINE) yesterday. Today the pain continues but maybe a little eased. He was scheduled for a magnetic resonance imaging (MRI) and follow-up with cardiology on the 23rd. Follow-up would be after the patient was seen. The outcome was reported as not recovered. Documents held by sender: None.
Age: 39.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Adverse reaction, Electrocardiogram PR interval, Electrocardiogram QRS complex normal, Electrocardiogram QT interval normal, Electrocardiogram ST segment normal
Clinical narrative: Initial report received on 24 August 2011 via a third party query tool search to the VAERS database, under reference number 426261. A 39-year-old male patient with GERD (gastroesophageal reflux disease), chronic right patellofemoral syndrome, left iliotibial band syndrome, chronic nerve pain at site of right inguinal herniorrhaphy, lumbago; and medical history of diverticulitis (resolved) and subcutaneous removal of benign lipoma, had received the following vaccinations on 15 June 2011: ACAM2000 (lot number VV04-003-A) and 10 days later experienced a robust take with large vaccine reaction greater than 12 cm (VAERS coded adverse reaction). There was no evidence of superimposed bacterial infection and the reaction worsened over the next few days. The patient also had mildly inflamed lymph nodes (coded by VAERS as inflammation) but not the fluctuant enlargement that would warrant further evaluation of a secondary bacterial infection. Upon questioning of the patient, the patient admitted to some mild positional chest pain that he attributed to his GERD. An EKG was performed to rule out myopericarditis. The EKG revealed PR: 170ms, QSR: 90ms, QT interval: 410ms, rate: 63, rhythm: sinus arrhythmia, axis: normal, and ST segment changes: none. Interpretation was normal variant ECG. Recovery status was unknown. Note: The manufacturer also captured chest pain (positional) as an event. Documents held by sender: None.
Age: 39.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Electrocardiogram normal, Inflammation
Clinical narrative: Initial report received on 24 August 2011 via a third party query tool search to the VAERS database, under reference number 426261. A 39-year-old male patient with GERD (gastroesophageal reflux disease), chronic right patellofemoral syndrome, left iliotibial band syndrome, chronic nerve pain at site of right inguinal herniorrhaphy, lumbago; and medical history of diverticulitis (resolved) and subcutaneous removal of benign lipoma, had received the following vaccinations on 15 June 2011: ACAM2000 (lot number VV04-003-A) and 10 days later experienced a robust take with large vaccine reaction greater than 12 cm (VAERS coded adverse reaction). There was no evidence of superimposed bacterial infection and the reaction worsened over the next few days. The patient also had mildly inflamed lymph nodes (coded by VAERS as inflammation) but not the fluctuant enlargement that would warrant further evaluation of a secondary bacterial infection. Upon questioning of the patient, the patient admitted to some mild positional chest pain that he attributed to his GERD. An EKG was performed to rule out myopericarditis. The EKG revealed PR: 170ms, QSR: 90ms, QT interval: 410ms, rate: 63, rhythm: sinus arrhythmia, axis: normal, and ST segment changes: none. Interpretation was normal variant ECG. Recovery status was unknown. Note: The manufacturer also captured chest pain (positional) as an event. Documents held by sender: None.
Age: 39.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Electrocardiogram normal, Lymphadenopathy, Robust take following exposure to vaccinia virus
Clinical narrative: Initial report received on 24 August 2011 via a third party query tool search to the VAERS database, under reference number 426261. A 39-year-old male patient with GERD (gastroesophageal reflux disease), chronic right patellofemoral syndrome, left iliotibial band syndrome, chronic nerve pain at site of right inguinal herniorrhaphy, lumbago; and medical history of diverticulitis (resolved) and subcutaneous removal of benign lipoma, had received the following vaccinations on 15 June 2011: ACAM2000 (lot number VV04-003-A) and 10 days later experienced a robust take with large vaccine reaction greater than 12 cm (VAERS coded adverse reaction). There was no evidence of superimposed bacterial infection and the reaction worsened over the next few days. The patient also had mildly inflamed lymph nodes (coded by VAERS as inflammation) but not the fluctuant enlargement that would warrant further evaluation of a secondary bacterial infection. Upon questioning of the patient, the patient admitted to some mild positional chest pain that he attributed to his GERD. An EKG was performed to rule out myopericarditis. The EKG revealed PR: 170ms, QSR: 90ms, QT interval: 410ms, rate: 63, rhythm: sinus arrhythmia, axis: normal, and ST segment changes: none. Interpretation was normal variant ECG. Recovery status was unknown. Note: The manufacturer also captured chest pain (positional) as an event. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Balance disorder, CSF protein increased, Convulsion, Demyelination, Full blood count
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Loss of consciousness, Mental status changes, Movement disorder, Muscular weakness, Pyrexia
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Spinal X-ray abnormal, White blood cell count
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Balance disorder, CSF protein increased, CSF white blood cell count negative, Condition aggravated, Convulsion
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Demyelination, Diagnostic procedure, Laboratory test abnormal, Loss of consciousness, Mental status changes
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Movement disorder, Muscular weakness, Pyrexia, Upper respiratory tract infection, Viral test
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: White blood cell count increased
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 426365. A 21-year-old male patient received the following initial dose vaccinations on 06 June 2011: ACAM2000 (sanofi pasteur lot number VV04003A), an intramuscular TYPHIM VI (sanofi pasteur lot number E04421), and an intramuscular anthrax (Emergent, lot number FAV281). The patient had no medical history. He had a current illness of an upper respiratory infection (URI) and was taking cold medications. On 21 June 2011, the patient required an Emergency visit and was admitted to the hospital with fever and mental status changes. He had a seizure leading to unconscious state. The patient was admitted to the hospital with PE that noted weak upper extremities and movement of lower extremities. The patient's laboratory data revealed a white blood cell count (WBC) of 24 K, cerebral spinal fluid (CSF) with elevated protein of 128 and a cell count of 3 WBC. The patient's radiographic findings were as follows: evidence of cervico-thoracic demyelination. Multiple viral studies were pending at this time. The patient was treated with one dose of cidofovir and corticosteroids. The patient's current status was that he was afebrile, with some weakness and minimal balance difficulties. The patient started with upper respiratory infection symptoms on 17 June 2011. The outcome was reported as unknown. Documents held by sender: None.
Age: 0.33
Sex: F
Vaccine: IPV, IPV
Symptoms: Dyskinesia, Fatigue, Injection site pain, Irritability, Swelling face
Clinical narrative: Adverse event within 2 hours of shot. Irritability, lethargy, loss of appetite, vomiting repeatedly, seizure, low fever.
Age: 0.33
Sex: F
Vaccine: IPV, IPV
Symptoms: Vomiting
Clinical narrative: Adverse event within 2 hours of shot. Irritability, lethargy, loss of appetite, vomiting repeatedly, seizure, low fever.
Age: 0.33
Sex: F
Vaccine: IPV, IPV
Symptoms: Convulsion, Decreased appetite, Irritability, Lethargy, Pyrexia
Clinical narrative: Adverse event within 2 hours of shot. Irritability, lethargy, loss of appetite, vomiting repeatedly, seizure, low fever.